Search Results - "Devilliers, H"

Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial by Jolly, M, Annapureddy, N, Arnaud, L, Devilliers, H

“…Objectives To quantify changes in generic patient-reported outcomes against clinically meaningful, disease activity measures in systemic lupus erythematosus…”
Get full text

Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19? by Moretto, F., Sixt, T., Devilliers, H., Abdallahoui, M., Eberl, I., Rogier, T., Buisson, M., Chavanet, P., Duong, M., Esteve, C., Mahy, S., Salmon-Rousseau, A., Catherine, F., Blot, M., Piroth, L.

“…•Antibiotics were prescribed to may patients with coronavirus disease 2019 during the first wave of the pandemic.•Bacterial co-infection seems to be rare,…”
Get full text

Patient-reported outcomes in lupus clinical trials with biologics by Annapureddy, N, Devilliers, H, Jolly, M

“…Therapeutic advances in systemic lupus erythematosus (SLE) are greatly needed. Despite advances in our knowledge of pathogenesis of the disease and targets,…”
Get full text

The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index by Devilliers, H, Bonithon-Kopp, C, Jolly, M

“…Objective The lupus impact tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of systemic lupus erythematosus or its treatment on…”
Get full text

Correlation between Objective structured clinical examinations (OSCE) and knowledge examination scores and analysis of factors associated with better OSCE success in fourth and fifth year medicine students at Dijon university hospital by Nguyen, M, Beltramo, G, Audia, S, Devilliers, H, Laurent, A, Blot, M

“…Objective structured clinical examinations (OSCEs) were introduced to evaluate students not only on their knowledge, but also on their clinical skills and…”
Get full text

Psychometric properties of MDHAQ/RAPID3 in patients with systemic lupus erythematosus by Annapureddy, N, Giangreco, D, Devilliers, H, Block, J A, Jolly, M

“…Background The Multidimensional Health Assessment Questionnaire (MDHAQ) is a patient-reported outcome (PRO) tool that includes the Routine Assessment of…”
Get full text

The JCMT Plane Survey: early results from the l = 30° field by Moore, T JT, Plume, R, Thompson, M A, Parsons, H, Urquhart, J S, Eden, D J, Dempsey, J T, Morgan, L K, Thomas, H S, Buckle, J, Brunt, C M, Butner, H, Carretero, D, Chrysostomou, A, deVilliers, H M, Fich, M, Hoare, M G, Manser, G, Mottram, J C, Natario, C, Olguin, F, Peretto, N, Polychroni, D, Redman, R O, Rigby, A J, Salji, C, Summers, L J, Berry, D, Currie, M J, Jenness, T, Pestalozzi, M, Traficante, A, Bastien, P, diFrancesco, J, Davis, C J, Evans, A, Friberg, P, Fuller, G A, Gibb, A G, Gibson, S, Hill, T, Johnstone, D, Joncas, G, Longmore, S N, Lumsden, S L, Martin, P G, Lu'o'ng, Q Nguyê[approximate]n, Pineda, J E, Purcell, C, Richer, J S, Schieven, G H, Shipman, R, Spaans, M, Taylor, A R, Viti, S, Weferling, B, White, G J, Zhu, M

“…We present early results from the JCMT (James Clerk Maxwell Telescope) Plane Survey (JPS), which has surveyed the northern inner Galactic plane between…”
Get full text

Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus by Pinto, B, Jolly, M, Dhooria, A, Grover, S, Raj, J M, Devilliers, H, Sharma, A

“…Background LupusPRO is a SLE specific patient reported outcomes measure developed and validated in the USA. This study aimed to validate the Hindi version of…”
Get full text

Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel–Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study by Luu, M., Vabres, P., Devilliers, H., Loffroy, R., Phan, A., Martin, L., Morice-Picard, F., Petit, F., Willems, M., Bessis, D., Jacquemont, M. L., Maruani, A., Chiaverini, C., Mirault, T., Clayton-Smith, J., Carpentier, M., Fleck, C., Maurer, A., Yousfi, M., Parker, V. E. R., Semple, R. K., Bardou, M., Faivre, L.

“…ABSTRACT Purpose PIK3CA pathogenic variants in the PIK3CA-related overgrowth spectrum (PROS) activate phosphoinositide 3-kinase signaling, providing a…”
Get full text

Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus by Giangreco, D, Devilliers, H, Annapureddy, N, Block, J A, Jolly, M

“…Objective To evaluate the responsiveness of Lupus Impact Tracker (LIT) to changes in physician and patient disease activity assessments over time. Methods…”
Get full text

Preoperative inflammation is an independent factor of worse prognosis after colorectal cancer surgery by Bert, M., Devilliers, H., Orry, D., Rat, P., Facy, O., Ortega-Deballon, P.

“…We know that inflammation is related to colorectal cancer prognosis and to the onset of postoperative infections. This study aimed to understand the…”
Get full text

Colchicine and non-severe ocular inflammation excluding Behcet's disease: 16 cases and literature review by Rogier, T, Auvens, C, Thibault, T, Mouries-Martin, S, Muller, G, El Hssaini, N, Turcu, A, Besancenot, J-F, Bielefeld, P, Devilliers, H

“…INTRODUCTIONColchicine is a narrow therapeutic margin drug that does not have the adverse effects of corticosteroids and immunosuppressants. Its use in…”
Get full text

Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study by Meunier-Beillard, N., Ponthier, N., Lepage, C., Gagnaire, A., Gheringuelli, F., Bengrine, L., Boudrant, A., Rambach, L., Quipourt, V., Devilliers, H., Lejeune, Catherine

“…Purpose Family caregivers play an important role in caring for patients with advanced cancer. To become competent, individuals must draw on and mobilise an…”
Get full text

Use of biotherapy in the management of Behçet's disease in a department of internal medicine by Wanvoegbe, F A, Turcu, A, Bach, B, Devilliers, H, Muller, G, Deschasse, C, Besancenot, J F, Bron, A, Bielefeld, P

“…Behçet's disease (BD) is a recurrent multisystemic disease responsible for occlusive vasculitis with arterial, venous and capillary involvement. The aim of…”
Get full text

Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus by Mathian, A., Devilliers, H., Krivine, A., Costedoat‐Chalumeau, N., Haroche, J., Huong, D. Boutin‐Le Thi, Wechsler, B., Hervier, B., Miyara, M., Morel, N., Le Corre, N., Arnaud, L., Piette, J. C., Musset, L., Autran, B., Rozenberg, F., Amoura, Z.

“…Objective To assess the factors influencing the efficacy of 2 injections of a pandemic 2009 influenza A (H1N1) vaccine in patients with systemic lupus…”
Get full text

Hyper-IgE in internal medicine by Devilliers, H, Turcu, A, Vernier, N, Muller, G, Bielefeld, P, Bonniaud, P, Besancenot, J-F

“…Hyper-IgE may be found under many pathological conditions. The role of IgE is essentially associated with the occurrence of allergic manifestations, which may…”
Get full text

Scleritis and systemic diseases: What should know the internist? by Bielefeld, P, Saadoun, D, Héron, E, Abad, S, Devilliers, H, Deschasse, C, Trad, S, Sène, D, Kaplanski, G, Sève, P

“…Scleritis is an inflammatory disease of the sclera; outer tunic of the eye on which the oculomotor muscles are inserted. It can be associated with a systemic…”
Get full text

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18–20 September 2015 by Benveniste, Olivier, Rider, Lisa G., Aggarwal, R., Allenbach, Y., Benveniste, O., De Bleecker, J.L., de Groot, I., Devilliers, H., Hilton-Jones, D., Hogrel, J.-Y., Lundberg, I.E., Mammen, A.L., Oakley, Oddis, C., Padberg, G., Ponce, D., Rider, L.G., Rose, M.R., Sanner, H., Selva- O'Callaghan, A., de Visser, M., Wells, A., Werth, V.P.

“…•The phenotypes of the idiopathic inflammatory myopathies (IIM) are discussed.•The inclusion criteria for future clinical trials for IIM are discussed.•The…”
Get full text

Quality of life measures in SLE: An update by Devilliers, H, Vernier, N, Muller, G, Turcu, A, Samson, M, Bielefeld, P, Besancenot, J-F

“…Systemic lupus erythematosus (SLE) is a chronic disease that considerably hampers patient's daily living. Qualitative studies with patients' interviews have…”
Get full text

P.21.9 Responsiveness of muscle testing and functions in a retrospective 51 inflammatory myopathies patient series by Devilliers, H, Shewaro, N, Allenbach, Y, Rigolet, A, Benveniste, O

“…Some criteria have been developed to assess muscle strength in inflammatory myopathies, but with no consensus. We evaluated at baseline and 6 month later…”
Get full text